Endothelial Cell Death Induced by Tumor Necrosis Factor-α Is Inhibited by the Bcl-2 Family Member, A1*
暂无分享,去创建一个
[1] David Wallach,et al. Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell Death , 1996, Cell.
[2] Matthias Mann,et al. FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex , 1996, Cell.
[3] V. Modur,et al. Endothelial Cell Inflammatory Responses to Tumor Necrosis Factor α , 1996, The Journal of Biological Chemistry.
[4] C. Borner,et al. Bcl-2 interrupts the ceramide-mediated pathway of cell death. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[5] Y. Hannun,et al. prICE: a downstream target for ceramide-induced apoptosis and for the inhibitory action of Bcl-2. , 1996, The Biochemical journal.
[6] S. Hakomori,et al. Regulatory role of ceramide in interleukin (IL)-1 beta-induced E-selectin expression in human umbilical vein endothelial cells. Ceramide enhances IL-1 beta action, but is not sufficient for E-selectin expression. , 1996, The Journal of biological chemistry.
[7] A. Karsan,et al. Cloning of human Bcl-2 homologue: inflammatory cytokines induce human A1 in cultured endothelial cells. , 1996, Blood.
[8] L. Zon,et al. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis , 1996, Nature.
[9] A. Chinnaiyan,et al. FADD/MORT1 Is a Common Mediator of CD95 (Fas/APO-1) and Tumor Necrosis Factor Receptor-induced Apoptosis (*) , 1996, The Journal of Biological Chemistry.
[10] John Calvin Reed,et al. A1, a Bcl-2 family member, prolongs cell survival and permits myeloid differentiation. , 1996, Blood.
[11] Hong-Bing Shu,et al. TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.
[12] J. Dickinson,et al. Plasminogen Activator Inhibitor Type 2 Inhibits Tumor Necrosis Factor α-induced Apoptosis , 1995, The Journal of Biological Chemistry.
[13] H. Umehara,et al. Requirement of AP-1 for Ceramide-induced Apoptosis in Human Leukemia HL-60 Cells (*) , 1995, The Journal of Biological Chemistry.
[14] D. Brenner,et al. Ceramide Activates the Stress-activated Protein Kinases (*) , 1995, The Journal of Biological Chemistry.
[15] K. Scotto,et al. Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals , 1995, Cell.
[16] T. Behrens,et al. Bcl-xL rescues WEHI 231 B lymphocytes from oxidant-mediated death following diverse apoptotic stimuli. , 1995, Journal of immunology.
[17] V. Dixit,et al. Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. , 1995, Oncogene.
[18] Z. Fuks,et al. Ceramide: a signal for apoptosis or mitogenesis? , 1995, The Journal of experimental medicine.
[19] T. Mak,et al. CD28 signals through acidic sphingomyelinase , 1995, The Journal of experimental medicine.
[20] Arul M. Chinnaiyan,et al. FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis , 1995, Cell.
[21] D. Goeddel,et al. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation , 1995, Cell.
[22] J. Camonis,et al. A Novel Protein That Interacts with the Death Domain of Fas/APO1 Contains a Sequence Motif Related to the Death Domain (*) , 1995, The Journal of Biological Chemistry.
[23] S. Grant,et al. Attenuation of ceramide-induced apoptosis by diglyceride in human myeloid leukemia cells. , 1994, The Journal of biological chemistry.
[24] M. Krönke,et al. The role of diacylglycerol and ceramide in tumor necrosis factor and interleukin‐1 signal transduction , 1994, Journal of leukocyte biology.
[25] A. Haimovitz-Friedman,et al. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis , 1994, The Journal of experimental medicine.
[26] L. Sanz,et al. Protein kinase C zeta isoform is critical for kappa B-dependent promoter activation by sphingomyelinase. , 1994, The Journal of biological chemistry.
[27] J. Michaeli,et al. Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. , 1994, Cancer research.
[28] S. Grant,et al. Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[29] John Calvin Reed. Bcl-2 and the regulation of programmed cell death , 1994, The Journal of cell biology.
[30] C. Thompson,et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death , 1993, Cell.
[31] W. Fiers,et al. Effect of bcl-2 proto-oncogene expression on cellular sensitivity to tumor necrosis factor-mediated cytotoxicity. , 1993, Oncogene.
[32] Y. Hannun,et al. Programmed cell death induced by ceramide. , 1993, Science.
[33] T. Hennet,et al. Expression of BCL-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity. , 1993, Cancer research.
[34] R. Swerlick,et al. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. , 1992, The Journal of investigative dermatology.
[35] V. Dixit,et al. The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. , 1992, The Journal of biological chemistry.
[36] C. Baglioni,et al. Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2. , 1991, The Journal of biological chemistry.
[37] R. Cotran,et al. The role of endothelial cells in inflammation. , 1990, Transplantation.
[38] Y. Shimada,et al. Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. , 1990, Biochemical and biophysical research communications.
[39] R. Cotran,et al. Cytokines and endothelial cell biology. , 1990, Physiological reviews.
[40] Miller Ad,et al. Improved Retroviral Vectors for Gene Transfer and Expression , 1989 .
[41] G. Wong,et al. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor , 1989, Cell.
[42] T. Pohlman,et al. Human endothelial cell response to lipopolysaccharide, interleukin-1, and tumor necrosis factor is regulated by protein synthesis. , 1989, Cellular immunology.
[43] J. Minna,et al. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. , 1987, Cancer research.
[44] B. Aggarwal,et al. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. , 1985, Science.
[45] D. Wallach. Preparations of lymphotoxin induce resistance to their own cytotoxic effect. , 1984, Journal of immunology.
[46] T. Maciag,et al. An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[47] R L Kassel,et al. An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[48] Daniel G. Miller,et al. Use of retroviral vectors for gene transfer and expression. , 1993, Methods in enzymology.
[49] H. Wepsic,et al. The effects of protein kinase inhibitors on lymphocyte blastogenesis and GVHD-induced splenomegaly. , 1989, Immunopharmacology and immunotoxicology.
[50] D. Wallach. Cytotoxins (tumour necrosis factor, lymphotoxin and others): molecular and functional characteristics and interactions with interferons. , 1986, Interferon.